Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.
Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial. medRxiv. 2026 Jun 24.
PMID: 42396282
Translating Cancer Science Into Cancer Care: Using Serious Illness Communication Frameworks to Deliver High-Quality Person-Centered Care in Neuro-Oncology.
Translating Cancer Science Into Cancer Care: Using Serious Illness Communication Frameworks to Deliver High-Quality Person-Centered Care in Neuro-Oncology. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e525426.
PMID: 42102343
NCCN Guidelines® Insights: Distress Management, Version 1.2026.
NCCN Guidelines® Insights: Distress Management, Version 1.2026. J Natl Compr Canc Netw. 2026 Apr; 24(4).
PMID: 41956112
Managing Cancer and Living Meaningfully Therapy Delivered as a novel remote intervention in individuals diagnosed with a Primary Central Nervous System Tumor.
Managing Cancer and Living Meaningfully Therapy Delivered as a novel remote intervention in individuals diagnosed with a Primary Central Nervous System Tumor. medRxiv. 2026 Jan 08.
PMID: 41542659
Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.
Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative. Neuro Oncol. 2025 Oct 14; 27(9):2399-2414.
PMID: 40293144
From discovery to delivery: the spectrum of decisional supports for people with brain tumors.
From discovery to delivery: the spectrum of decisional supports for people with brain tumors. Neurooncol Pract. 2025 Dec; 12(6):929-930.
PMID: 41458938
Healthcare access and utilization of deep brain stimulation and supplementary care in black and white patients with Parkinson's disease.
Healthcare access and utilization of deep brain stimulation and supplementary care in black and white patients with Parkinson's disease. Parkinsonism Relat Disord. 2025 Nov; 140:108057.
PMID: 40986940
Proceedings of the First Neuropalliative Care Research Summit (NeuroCARES).
Proceedings of the First Neuropalliative Care Research Summit (NeuroCARES). J Pain Symptom Manage. 2025 Dec; 70(6):e366-e376.
PMID: 40876664
Research Priorities in Neuropalliative Care: A Consensus Statement From the International Neuropalliative Care Society.
Research Priorities in Neuropalliative Care: A Consensus Statement From the International Neuropalliative Care Society. JAMA Neurol. 2025 Mar 01; 82(3):295-302.
PMID: 39899319
Palliative care services in neuro-oncology: Mind the gap.
Palliative care services in neuro-oncology: Mind the gap. Neurooncol Pract. 2024 Oct; 11(5):513-514.
PMID: 39279767